convoy therapeutics

About:

Convoy Therapeutics is based upon the proprietary Skin-Penetrating And Cell Entering (SPACE) peptide technology.

Twitter/X: convoytx

Description:

Convoy Therapeutics, a subsidiary of ACTUS Biotechnologies, was founded in 2011 based upon the proprietary Skin-Penetrating And Cell Entering (SPACE) peptide technology developed by Professor Samir Mitragotri and his laboratory at University of California at Santa Barbara. The company is focused on enhancing the patient experience using its proprietary platform technology and aggressively advancing this platform technology through the research and development process.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tucson, Arizona, United States

Founded Date:

2011-01-01

Contact Email:

debbie(AT)actusbiotech.com

Founders:

Samir Mitragotri

Number of Employees:

11-50

Last Funding Date:

2012-05-15

IPO Status:

Private

Industries: